WHY BOTHER? –
June 9, 2023 – “The use of psychedelic and hallucinogenic drugs for a range of therapeutic uses is increasing, given accumulating yet still preliminary data from randomized trials on clinical effectiveness,” said Katherine Keyes, professor of epidemiology at Columbia Mailman School and lead author of the study, said in the release. “With increased visibility for medical and therapeutic use, however, potentially comes diversion and unregulated product availability, as well as a lack of understanding among the public of potential risks.”
Keyes added that because approved therapeutic use of psychedelics under the observation of a trained professional remains uncommon within the US, “the trends we observe here are undoubtedly in nonmedical and nontherapeutic use.”
